Mirror image of a mouse brain with Niemann-Pick type C1 (NPC1) neurodegenerative disease. A major way to assess the impact of a therapeutic potential on the central nervous system is to assess cerebellar pathology in mice. Eunice Kennedy Shriver's National Institute of Child Health and Human Development (NICHD) researchers have found that an experimental drug can stabilize or slow the progression of NPC1.